Translational Psychiatry  open-access icon

Journal Title

  • Translational Psychiatry

ISSN

  • P 2158-3188

Publisher

  • Nature Publishing Group

Listed on(Coverage)

JCR 2013-2019
SJR 2012-2019
CiteScore 2012-2019
SCIE 2012-2021
CC 2016-2021
SCOPUS 2017-2020
MEDLINE 2016-2021
DOAJ 2017-2021
EMBASE 2016-2020

OA Info.

OA open-access icon

based on the information

  • 2017;2018;2019;2020;2021;
Keywords neuroscience, translational psychiatry
Review Process Blind peer review
Journal info. pages
Licences CC BY
Copyrights No
DOAJ Coverage
  • Added on Date : 2012-06-11T13:51:36Z
Subject(s) Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • ENGLAND

Aime & Scopes

  • Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.

Article List

1 - 0 out of 0 results.

1

BROWSE